Breakout
24+Portfolio
We invest in early‑stage bioscience companies developing cellular solutions for human health and sustainability.
Where they invest
Geography
Portfolio footprintHover a country to explore
- United States of America
- 82.6%
- United Kingdom
- 13.0%
- Jordan
- 4.3%
Darker countries represent a larger share of the portfolio.
What they back
Industries
- Biotechnology
- 69.6%
- Artificial Intelligence
- 26.1%
- Clean Technology
- 17.4%
- Healthcare Technology
- 17.4%
- Data & Analytics
- 13.0%
- Chemical Technology
- 13.0%
% of all portfolio companies. Industry categories can overlap.
Stages
Stage indicator
No stages listed
Fund details
Funds
Fund I
$100M
Fund II
$150M
Fund III
$250M